New drug combo aims to stop blood cancer relapse after transplant in kids
Disease control
Recruiting now
This study tests whether giving two drugs, decitabine and filgrastim, after a stem cell transplant can help prevent blood cancers like AML and MDS from coming back in children and young adults. About 37 participants will receive the drug combination for up to 6 cycles. The main g…
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated Jun 17, 2026 12:02 UTC